NRG/HER Restoration of the Lung Epithelium After Injury

NRG/HER 损伤后肺上皮的恢复

基本信息

  • 批准号:
    7255627
  • 负责人:
  • 金额:
    $ 36.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Acute lung injury with its associated damage to the pulmonary epithelium and the resultant fibrosis affects approximately 20/100,000 /year in the US. Pulmonary epithelial cells, growth factors and their cognate receptors play an active role in this recovery. However, which growth factors and receptors participate and what processes they direct remains unclear. My laboratory has identified a membrane bound receptor tyrosine kinase family in the lung, the human epidermal growth factor-like receptor family (HER2, 3 and 4), whose expression is localized to the pulmonary epithelium. Our studies of the HER system and its ligand, Neuregulin-1 (NRG-1), suggest they play an important role in the recovery of pulmonary epithelial cells from injury. This knowledge has led us to hypothesize that: Activation of the HER2/HER3 receptor in pulmonary epithelial cells during or after lung injury directs a fibrotic response via the elaboration of pro-fibrotic cytokine cascades and promotes epithelial cell repair. The goal of this proposal is to test this hypothesis in vivo using transgenic mice with lung specific defects in the NRG-1/HER2/HER3 axis and define mechanisms of receptor activation and downstream signaling in vitro. In this application we propose to: 1) Define the HER2/HER3 receptor complex's role in the regulation of fibrotic cytokine cascades using unique transgenic mouse strains with lung specific expression of a dominant negative HERS receptor, 2) Define mechanisms of HER2/HER3 receptor activation during injury that results in fibrotic cytokine production, and 3) Use a dominant negative STAT3 molecule to understand the HER2/HER3 induced activation of STAT3, and its role in repair of the epithelium. Bleomycin and mechanical injury models will be used in vivo and in vitro to initiate lung injury and determine the effect(s) of HER2/HER3 receptor activation and inactivation on the epithelium's ability to direct fibrosis, inflammation, proliferation, and apoptosis. The identification of growth factors, receptors, and induced signals important in the pulmonary repair process will lay the groundwork for identification of new therapeutic strategies for patients with fibrotic or otherwise damaged lungs.
描述(由申请人提供):在美国,急性肺损伤及其相关的肺上皮损伤和由此产生的纤维化发生率约为20/10万/年。肺上皮细胞、生长因子及其同源受体在这种恢复中起积极作用。然而,哪些生长因子和受体参与其中,以及它们所指导的过程尚不清楚。我的实验室已经在肺中发现了一个膜结合受体酪氨酸激酶家族,即人表皮生长因子样受体家族(HER2、3和4),其表达局限于肺上皮。我们对HER系统及其配体神经调节蛋白-1 (NRG-1)的研究表明,它们在肺上皮细胞损伤后的恢复中发挥重要作用。在肺损伤期间或之后,肺上皮细胞中HER2/HER3受体的激活通过促纤维化细胞因子级联反应指导纤维化反应,并促进上皮细胞修复。本课题的目标是在体内利用NRG-1/HER2/HER3轴肺特异性缺陷的转基因小鼠来验证这一假设,并在体外确定受体激活和下游信号传导的机制。在这项应用中,我们提出:1)利用具有肺特异性表达显性阴性her受体的独特转基因小鼠菌株,确定HER2/HER3受体复合物在纤维化细胞因子级联反应中的调节作用;2)确定损伤期间HER2/HER3受体激活导致纤维化细胞因子产生的机制;3)使用显性阴性STAT3分子了解HER2/HER3诱导的STAT3激活及其在上皮修复中的作用。博莱霉素和机械损伤模型将在体内和体外启动肺损伤,并确定HER2/HER3受体激活和失活对上皮纤维化、炎症、增殖和凋亡能力的影响。鉴定在肺修复过程中重要的生长因子、受体和诱导信号将为纤维化或其他肺损伤患者确定新的治疗策略奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY A KERN其他文献

JEFFREY A KERN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY A KERN', 18)}}的其他基金

Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
确定通过癌症免疫治疗减轻免疫相关不良事件的途径
  • 批准号:
    10395923
  • 财政年份:
    2020
  • 资助金额:
    $ 36.62万
  • 项目类别:
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
确定通过癌症免疫治疗减轻免疫相关不良事件的途径
  • 批准号:
    10593951
  • 财政年份:
    2020
  • 资助金额:
    $ 36.62万
  • 项目类别:
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
确定通过癌症免疫治疗减轻免疫相关不良事件的途径
  • 批准号:
    9920595
  • 财政年份:
    2020
  • 资助金额:
    $ 36.62万
  • 项目类别:
NRG/HER Restoration of the Lung Epithelium After Injury
NRG/HER 损伤后肺上皮的恢复
  • 批准号:
    6979291
  • 财政年份:
    2005
  • 资助金额:
    $ 36.62万
  • 项目类别:
NRG/HER Restoration of the Lung Epithelium After Injury
NRG/HER 损伤后肺上皮的恢复
  • 批准号:
    7459815
  • 财政年份:
    2005
  • 资助金额:
    $ 36.62万
  • 项目类别:
NRG/HER Restoration of the Lung Epithelium After Injury
NRG/HER 损伤后肺上皮的恢复
  • 批准号:
    7116266
  • 财政年份:
    2005
  • 资助金额:
    $ 36.62万
  • 项目类别:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
她的受体家族、调节蛋白和肺部发育
  • 批准号:
    6476863
  • 财政年份:
    2000
  • 资助金额:
    $ 36.62万
  • 项目类别:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
她的受体家族、调节蛋白和肺部发育
  • 批准号:
    6330165
  • 财政年份:
    2000
  • 资助金额:
    $ 36.62万
  • 项目类别:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
她的受体家族、调节蛋白和肺部发育
  • 批准号:
    2758559
  • 财政年份:
    1998
  • 资助金额:
    $ 36.62万
  • 项目类别:
HER RECEPTOR FAMILY, HEREGULIN AND LUNG DEVELOPMENT
她的受体家族、调节蛋白和肺部发育
  • 批准号:
    6125878
  • 财政年份:
    1998
  • 资助金额:
    $ 36.62万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.62万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了